HGH Frag 176-191

Description

HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal portion (amino acids 176-191) of human growth hormone (hGH). This specific fragment has been isolated for research because it contains the region of hGH believed to be responsible for its lipolytic (fat-reducing) activity, while lacking the growth-promoting and diabetogenic effects associated with the full-length hormone. HGH Frag 176-191 has been studied for its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) in adipose tissue through mechanisms that are distinct from those of intact growth hormone. The fragment interacts with a specific binding site on fat cell membranes, triggering a cascade that involves beta-3 adrenergic receptor-mediated pathways. It represents a valuable tool for studying growth hormone-related metabolic pathways in isolation. Supplied as a lyophilized powder. For research use only.